Last reviewed · How we verify
Influenzae vaccine
Influenzae vaccine is a Biologic drug developed by PT Bio Farma. It is currently FDA-approved. Also known as: Fluzone.
At a glance
| Generic name | Influenzae vaccine |
|---|---|
| Also known as | Fluzone |
| Sponsor | PT Bio Farma |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies (PHASE3)
- Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (PHASE3)
- A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants (PHASE2)
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations (PHASE4)
- Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children (PHASE4)
- Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants (PHASE1, PHASE2)
- Phase 3 Study of BK1310 in Healthy Infants (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Influenzae vaccine CI brief — competitive landscape report
- Influenzae vaccine updates RSS · CI watch RSS
- PT Bio Farma portfolio CI
Frequently asked questions about Influenzae vaccine
What is Influenzae vaccine?
Influenzae vaccine is a Biologic drug developed by PT Bio Farma.
Who makes Influenzae vaccine?
Influenzae vaccine is developed and marketed by PT Bio Farma (see full PT Bio Farma pipeline at /company/pt-bio-farma).
Is Influenzae vaccine also known as anything else?
Influenzae vaccine is also known as Fluzone.
What development phase is Influenzae vaccine in?
Influenzae vaccine is FDA-approved (marketed).
Related
- Manufacturer: PT Bio Farma — full pipeline
- Also known as: Fluzone
- Compare: Influenzae vaccine vs similar drugs
- Pricing: Influenzae vaccine cost, discount & access